AI assistant
Sending…
Context Therapeutics Inc. — Director's Dealing 2021
Nov 1, 2021
34269_dirs_2021-11-01_14adaea3-3e4c-4bd5-8ac3-ea0ce2c8f29f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2021-11-01
Reporting Person: Minai-Azary Jennifer Lynn (Chief Financial Officer)
More from Context Therapeutics Inc.
Regulatory Filings
2026
May 18
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Major Shareholding Notification
2026
Feb 17